Clinical Trial Update: Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating Rosiglitazone Maleate in people with type 2 diabetes mellitus to assess the utility of novel technologies and biomarker…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Avandia (rosiglitazone)
• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED